Fractyl Health, Inc. - Common Stock (NQ:GUTS)

2.000 -0.100 (-4.76%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Price and Volume

Volume	2,711,098
Open	2.110
Bid (Size)	2.000 (1,900)
Ask (Size)	2.030 (1,000)
Prev. Close	2.100
Today's Range	1.990 - 2.130
52wk Range	0.8250 - 3.030
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness

January 06, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category

January 05, 2026

From Fractyl Health, Inc.

Via GlobeNewswire

Performance

YTD	-11.1%	-11.1%
1 Month	-13.0%	-13.0%
3 Month	+49.3%	+49.3%
6 Month	+27.4%	+27.4%
1 Year	+8.1%	+8.1%

More News

Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones

December 15, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

GUTS Stock Rallied About 28% Today – Here’s Why ↗

September 26, 2025

Via Stocktwits

Fractyl Health's Revita Procedure Helps Patients Keep Weight Off After Stopping GLP-1 Drugs ↗

December 02, 2025

Via Benzinga

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

December 02, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference

December 01, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl (GUTS) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Via The Motley Fool

Fractyl Health Reports Third Quarter 2025 Results; Revita® Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027

November 12, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Preview: Fractyl Health's Earnings ↗

November 11, 2025

Via Benzinga

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

November 05, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity

October 07, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Unusual volume stocks are being observed in Wednesday's session. ↗

October 01, 2025

Via Chartmill

MAGA Stocks Undercard: SNYR GUTS MRM MYSE Under $3 To Watch Now….more inside

September 26, 2025

Via AB Newswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 26, 2025

Via Benzinga

What's going on in today's pre-market session ↗

September 26, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 26, 2025

Via Benzinga

Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock

September 26, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation

September 26, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

This Broadcom Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

September 15, 2025

Via Benzinga

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth

September 03, 2025

From Fractyl Health, Inc.

Via GlobeNewswire

This Oddity Tech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

August 28, 2025

Via Benzinga

Fractyl Health Posts 62% Wider Q2 Loss ↗

August 12, 2025

Via The Motley Fool

FRACTYL HEALTH INC (NASDAQ:GUTS) Reports Wider-Than-Expected Q2 2025 Loss Amid Clinical Progress ↗

August 12, 2025

Via Chartmill

Frequently Asked Questions

Is Fractyl Health, Inc. - Common Stock publicly traded?

Yes, Fractyl Health, Inc. - Common Stock is publicly traded.

What exchange does Fractyl Health, Inc. - Common Stock trade on?

Fractyl Health, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Fractyl Health, Inc. - Common Stock?

The ticker symbol for Fractyl Health, Inc. - Common Stock is GUTS on the Nasdaq Stock Market

What is the current price of Fractyl Health, Inc. - Common Stock?

The current price of Fractyl Health, Inc. - Common Stock is 2.000

When was Fractyl Health, Inc. - Common Stock last traded?

The last trade of Fractyl Health, Inc. - Common Stock was at 01/09/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.